Crumbs3 is a critical factor that regulates invasion and metastasis of colon adenocarcinoma via the specific interaction with FGFR1.
Crumbs3 is a critical factor that regulates invasion and metastasis of colon adenocarcinoma via the specific interaction with FGFR1.
复制标题
Crumbs3是通过与FGFR1特异性相互作用调节结肠腺癌侵袭和转移的关键因子。
作者:
Iioka H;Saito K;Sakaguchi M;Tachibana T;Homma K;Kondo E.
Epithelial cell polarity regulatorCrumbs3(Crb3), a mammalian homolog within theDrosophila Crbgene family, was initially identified as an essential embryonic development factor. It is recently implicated in tumor suppression, though its specific functions are controversial. We here demonstrate thatCrb3strongly promotes tumor invasion and metastasis of human colon adenocarcinoma cells. Crb3 centrality to tumor migration was supported by strong expression at invasive front and metastatic foci of colonic adenocarcinoma of the patient tissues. Accordingly, two differentCrb3‐knockout (KO) lines,Crb3‐KO (Crb3−/−) DLD‐1 andCrb3‐KO WiDr from human colonic adenocarcinomas, were generated by the CRISPR‐Cas9 system.Crb3‐KODLD‐1 cells exhibited loss of cellular mobilityin vitroand dramatic suppression of liver metastasesin vivoin contrast to the wild type of DLD‐1. Unlike DLD‐1,Crb3‐KOWiDr mobility and metastasis were unaffected, which were similar to wild‐type WiDr. Proteome analysis of Crb3‐coimmunopreciptated proteins identified different respective fibroblast growth factor receptor (FGFR) isotypes specifically bound to Crb3 isoform a through their intracellular domain. In DLD‐1, Crb3 showed membranous localization of FGFR1 leading to its functional activation, whereas Crb3 bound to cytoplasmic FGFR4 in WiDr without FGFR1 expression, leading to cellular growth. Correlative expression between Crb3 and FGFR1 was consistently detected in primary and metastatic colorectal cancer patient tissues. Taking these together, Crb3 critically accelerates cell migration, namely invasion and metastasis of human colon cancers, through specific interaction to FGFR1 on colon cancer cells.